September 22, 2025 · Form 4 insider transaction
MACMILLAN STEPHEN P sold 38,700 shares of Hologic, Inc. at $67.32 per share, a transaction worth $2.61M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Transaction pursuant to an existing Rule 10b5-1 trading plan adopted December 12, 2024 to exercise and sell stock options expiring November 5, 2025.; The price reported is the weighted average price per share. Shares were sold in multiple transactions at prices ranging from $67.28 to $67.61 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price.; Includes 1,079,673 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan.; Includes 346 shares acquired pursuant to the Issuer's employee stock purchase plan since the date of the Reporting Person's most recently filed Form 4.